Jones Financial Companies
INAB icon

Jones Financial Companies’s IN8bio INAB Stock Holding History

Jones Financial Companies’s Portfolio INAB Stock Details INAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.08K Sell
768
-460
-37% -$890 ﹤0.01% 4330
2025
Q4 		$2.87K Buy
+1,228
New +$2.33K ﹤0.01% 3714

Other funds holding INAB

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return

Jones Financial Companies's INAB Position: Q1 2026 in Review

Jones Financial Companies reduced its IN8bio (INAB) stake by 37% in Q1 2026, selling an estimated $890 and leaving 768 shares worth $1.08K. The position accounts for ﹤0.01% of the portfolio, ranked #4330.

Jones Financial Companies first reported a position in INAB in Q4 2025 and has held it in 2 quarters since. The position peaked at $2.87K in Q4 2025. 19 funds tracked by Wall St. Rank hold INAB as of Q1 2026.

  • Jones Financial Companies held 768 shares of IN8bio worth $1.08K as of Q1 2026.
  • Jones Financial Companies sold 460 IN8bio shares in Q1 2026, an estimated $890.
  • IN8bio made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #4330 holding.
  • Jones Financial Companies first reported a position in IN8bio in Q4 2025 and has held it in 2 quarters since.
  • Jones Financial Companies's IN8bio position peaked at $2.87K in Q4 2025.
  • 19 funds tracked by Wall St. Rank held IN8bio as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.